Neurofibromatosis - NYSORA

Explore NYSORA knowledge base for free:

Table of Contents

Contributors

Neurofibromatosis

Neurofibromatosis

Learning objectives

  • Signs and symptoms and management of neurofibromatosis

Definition and mechanisms

  • Neurofibromatoses are a group of genetic disorders that cause tumors to form on nerve tissue
  • Tumors can develop in the brain, spinal cord, or nerves
  • An autosomal dominant disorder caused by a genetic mutation in oncogenes
  • Three types of neurofibromatosis:
    • Neurofibromatosis 1: usually diagnosed in childhood
    • Neurofibromatosis 2: usually diagnosed in early adulthood
    • Schwannomatosis: usually diagnosed in early adulthood
  • Tumors are usually benign but can sometimes become malignant

Signs and symptoms

Neurofibromatosis 1
Neurofibromatosis 2Schwannomatosis
Flat, light brown spots on the skin (cafe au lait spots)
Freckling in the armpits or groin area
Tiny bumps on the iris of the eye (Lisch nodules)
Soft, pea-sized bumps on or under the skin (neurofibromas)
Bone deformities
Tumor on the optic nerve (optic glioma)
Learning disabilities
Large than average head size
Short stature
Signs and symptoms of NF2 usually result from the development of benign, slow-growing acoustic neuromas
Gradual hearing loss
Ringing in the ears
Poor balance
Headaches
Causes tumors to develop on the cranial, spinal, and peripheral nerves
Chronic pain, which can occur anywhere in the body and can be disabling
Numbness or weakness in various parts of the body
Loss of muscle

Sometimes NF2 can lead to the growth of schwannomas in other nerves, including the cranial, spinal, visual (optic), and peripheral nerves
Numbness and weakness in the arms or legs
Pain
Balance difficulties
Facial drop
Vision problems or cataracts
Seizures
Headache

Treatment

  • Surgical removal
  • Chemotherapy
  • Radiotherapy

Management

Neurofibromatosis, pehochromocytomas

Suggested reading

  • Fox CJ, Tomajian S, Kaye AJ, Russo S, Abadie JV, Kaye AD. Perioperative management of neurofibromatosis type 1. Ochsner J. 2012;12(2):111-121.
  • Griffiths, S., Durbridge, J.A., 2011. Anaesthetic implications of neurological disease in pregnancy. Continuing Education in Anaesthesia Critical Care & Pain 11, 157–161.
  • Hirsch NP, Murphy A, Radcliffe JJ. Neurofibromatosis: clinical presentations and anaesthetic implications. Br J Anaesth. 2001;86(4):555-564.

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com